William R. Sellers
Broad Institute · 836 works · 84,702 citations · h-index 119
Top works
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- The landscape of somatic copy-number alteration across human cancers
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
- Gene expression correlates of clinical prostate cancer behavior
- Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
- BRAF mutation predicts sensitivity to MEK inhibition
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
- Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
- Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
- High-throughput oncogene mutation profiling in human cancer
- Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
- Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
- Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
- Molecular characterization of the tumor microenvironment in breast cancer
- An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays
- Interaction between the retinoblastoma protein and the oncoprotein MDM2
- MEK1 mutations confer resistance to MEK and B-RAF inhibition
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy